Multimodal cell communication networks nominate immunotherapies for RCC subgroups with discrete T cell recruitment or expansion
Renal cell carcinoma (RCC) is amongst the most immune-infiltrated solid tumours, but only a small subset of patients achieves durable response to immune checkpoint blockade therapy. Efforts to characterize the immune microenvironment and molecular regulators responsible for treatment responses have explored numerous fa...